Please turn JavaScript on
Oncology Today with Dr Neil Love icon

Oncology Today with Dr Neil Love

We bring you the latest updates from Oncology Today with Dr Neil Love through a simple and fast subscription.

We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.

Unsubscribe at any time without hassle.

Oncology Today with Dr Neil Love's title: Oncology Today with Dr Neil Love

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.75 / day

Message History

Featuring an interview with Dr Matthew Lunning, including the following topics:

Tafasitamab for follicular lymphoma (0:00)frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)

CME information and select publicatio...


Read full story

Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:

Introduction (0:00)Prologue: Saturday Night Fever (1:35)Baby Boomers' Guide to Mechanisms of Action (3:07)Second-Line Treatment (12:36)Complications Associated with Bispecific Antibodies (23:41)Case Presentations (25:52)New Bispecific T-Cell Engagers — Surovatamig (26:24)Othe...

Read full story

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:

Multiple Myeloma (0:00)Introduction: ESMO 2026; Recent FDA Approvals (1:53)Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)Bispecific Antibodies — Dr Lonial (19:16)Antibody-Drug Conjugates — Dr Richardson (37:08)Up-Front Treatment; Cereblon E3 Ligase Modulators ...

Read full story

Featuring perspectives from Dr Neeraj Agarwal and Dr Emmanuel S Antonarakis, including the following topics:

Introduction: ESMO 2026; Recent FDA Approvals (0:00)Selection of Endocrine Therapy — Dr Antonarakis (2:24)Utility of PARP Inhibitors — Dr Agarwal (22:59)AKT Inhibition for PTEN-Deficient Disease — Dr Antonarakis (35:42)Radiopharmaceuticals — Dr Agarwal (45:02)
...

Read full story

Featuring perspectives from Dr Charles E Geyer Jr, Dr Maryam Lustberg, Dr Rita Nanda and Dr Seth Wander, including the following topics:

Breast Cancer Introduction: ESMO 2026; Recent FDA Approvals (0:00)ER-Positive Breast Cancer (5:01)HER2-Positive Breast Cancer (1:19:08)Triple-Negative Breast Cancer (1:48:54)


Read full story